
This is a list of
selective estrogen receptor modulator
Selective estrogen receptor modulators (SERMs), also known as estrogen receptor agonist/antagonists (ERAAs), are a class of drugs that act on the estrogen receptor (ER). A characteristic that distinguishes these substances from pure ER agonists ...
s (SERMs).
Approved
SERMs that have been approved for medical use include
anordrin
Anordrin (former developmental code name AF-53), also known as 2α,17α-diethynyl-A-nor-5α-androstane-2β,17β-diol dipropionate, is a synthetic, steroidal selective estrogen receptor modulator (SERM) which is used in China as an emergency contr ...
(+
mifepristone
Mifepristone, also known as RU-486, is a medication typically used in combination with misoprostol to bring about a medical abortion during pregnancy and manage early miscarriage. This combination is 97% effective during the first 63 days of ...
(Zi Yun)),
bazedoxifene (
+conjugated estrogens (Duavee)),
broparestrol
Broparestrol () (brand names Acnestrol, Longestrol; former developmental code name LN-107), also known as α-bromo-α,β-diphenyl-β-p-ethylphenylethylene (BDPE), is a synthetic, nonsteroidal selective estrogen receptor modulator (SERM) of the tr ...
(Acnestrol),
clomifene
Clomifene, also known as clomiphene, is a medication used to treat infertility in women who do not ovulate, including those with polycystic ovary syndrome. Use results in a greater chance of twins. It is taken by mouth once a day, with a course ...
(Clomid),
cyclofenil (Sexovid),
lasofoxifene
Lasofoxifene, sold under the brand name Fablyn, is a nonsteroidal selective estrogen receptor modulator (SERM) which is marketed by Pfizer in Lithuania and Portugal for the prevention and treatment of osteoporosis and for the treatment of vagina ...
(Fablyn),
ormeloxifene
Ormeloxifene, also known as centchroman, is one of the selective estrogen receptor modulators, or SERMs, a class of medication which acts on the estrogen receptor. It is best known as a nonsteroidal oral contraceptive which is taken once pe ...
(Centron, Novex, Novex-DS, Sevista),
ospemifene
Ospemifene (brand names Osphena and Senshio produced by Shionogi) is an oral medication indicated for the treatment of dyspareuniapain during sexual intercourseencountered by some women, more often in those who are post-menopausal. Ospemifene is ...
(Osphena; deaminohydroxytoremifene),
raloxifene
Raloxifene, sold under the brand name Evista among others, is a medication used to prevent and treat osteoporosis in postmenopausal women and those on glucocorticoids. For osteoporosis it is less preferred than bisphosphonates. It is also use ...
(Evista),
tamoxifen
Tamoxifen, sold under the brand name Nolvadex among others, is a selective estrogen receptor modulator used to prevent breast cancer in women and treat breast cancer in women and men. It is also being studied for other types of cancer. It has b ...
(Nolvadex), and
toremifene
Toremifene, sold under the brand name Fareston among others, is a medication which is used in the treatment of advanced breast cancer in postmenopausal women.https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020497s006lbl.pdf It is take ...
(Fareston; 4-chlorotamoxifen).
Clinical trials
SERMs that are currently under development and in clinical trials include
acolbifene
Acolbifene () (developmental code names EM-652, SCH-57068) is a nonsteroidal selective estrogen receptor modulator
Selective estrogen receptor modulators (SERMs), also known as estrogen receptor agonist/antagonists (ERAAs), are a class of drug ...
,
afimoxifene
Afimoxifene, also known as 4-hydroxytamoxifen (4-OHT) and by its tentative brand name TamoGel, is a selective estrogen receptor modulator (SERM) of the triphenylethylene group and an active metabolite of tamoxifen. The drug is under development u ...
(4-hydroxytamoxifen; metabolite of tamoxifen),
elacestrant,
enclomifene ((''E'')-clomifene),
endoxifen
Endoxifen, also known as 4-hydroxy-''N''-desmethyltamoxifen, is a nonsteroidal selective estrogen receptor modulator (SERM) of the triphenylethylene group as well as a protein kinase C (PKC) inhibitor. It is under development for the treatment of ...
(4-hydroxy-''N''-desmethyltamoxifen; metabolite of tamoxifen), and
zuclomifene ((''Z'')-clomifene).
[http://adisinsight.springer.com/]
Non-approved
SERMs that have not been approved for medical use include
arzoxifene,
brilanestrant,
clomifenoxide (clomiphene N-oxide; metabolite of clomifene),
droloxifene (3-hydroxytamoxifen),
etacstil,
fispemifene,
GW-7604 (4-hydroxyetacstil; metabolite of etacstil),
idoxifene (pyrrolidino-4-iodotamoxifen),
levormeloxifene ((
L)-ormeloxifene),
miproxifene,
nafoxidine
Nafoxidine (; developmental code names U-11,000A) or nafoxidine hydrochloride () is a nonsteroidal selective estrogen receptor modulator (SERM) or partial antiestrogen of the triphenylethylene group that was developed for the treatment of adva ...
,
nitromifene
Nitromifene (; also as the citrate salt nitromifene citrate (), developmental code names CI-628, CN-5518, CN-55945) is a nonsteroidal selective estrogen receptor modulator (SERM) related to triphenylethylenes like tamoxifen that was never mark ...
(CI-628),
NNC 45-0095,
panomifene,
pipendoxifene (ERA-923),
trioxifene
Trioxifene (INN) (developmental code name LY-133,314), or as the salt trioxifene mesylate ( USAN), is a selective estrogen receptor modulator (SERM) with competitive binding activity against estradiol for the ERα and antagonistic activity ag ...
, and
zindoxifene (D-16726).
Sivifene
Sivifene (INN, USAN; developmental code name A-007) is a small-molecule antineoplastic agent and immunomodulator that was under development in the 2000s by Tigris Pharmaceuticals (now Kirax Corporation) as a topical treatment for cutaneous cancer ...
(A-007) was initially thought to be a SERM due to its structural similarity to tamoxifen but it was subsequently found not to bind to the
estrogen receptor
Estrogen receptors (ERs) are a group of proteins found inside cells. They are receptors that are activated by the hormone estrogen (17β-estradiol). Two classes of ER exist: nuclear estrogen receptors ( ERα and ERβ), which are members of th ...
(ER).
Tesmilifene (DPPE; YMB-1002, BMS-217380-01) is also structurally related to tamoxifen but similarly does not bind to the ER and is not a SERM.
Structure
SERMs can be variously classified
structurally as
triphenylethylene
Triphenylethylene (TPE) is a simple aromatic hydrocarbon that possesses weak estrogenic activity. Its estrogenic effects were discovered in 1937. TPE was derived from structural modification of the more potent estrogen diethylstilbestrol, which ...
s (tamoxifen, clomifene, toremifene, droloxifene, idoxifene, ospemifene, fispemifene, afimoxifene, others),
benzothiophene
Benzothiophene is an aromatic organic compound with a molecular formula C8H6S and an odor similar to naphthalene (mothballs). It occurs naturally as a constituent of petroleum-related deposits such as lignite tar. Benzothiophene has no househo ...
s (raloxifene, arzoxifene),
indole
Indole is an aromatic heterocyclic organic compound with the formula C8 H7 N. It has a bicyclic structure, consisting of a six-membered benzene ring fused to a five-membered pyrrole ring. Indole is widely distributed in the natural environme ...
s (bazedoxifene, zindoxifene, pipendoxifene),
tetrahydronaphthalene
Tetralin (1,2,3,4-tetrahydronaphthalene) is a hydrocarbon having the chemical formula C10H12. It is a partially hydrogenated derivative of naphthalene. It is a colorless liquid that is used as a hydrogen-donor solvent.
Production
Tetralin is pr ...
s (lasofoxifene, nafoxidine), and
benzopyrans (acolbifene, ormeloxifene, levormeloxifene).
References
{{DEFAULTSORT:Selective estrogen receptor modulators
Selective estrogen receptor modulators
Biology-related lists